Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis

Standard

Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis. / von Arnim, U; Röhl, F-W; Miehlke, S; Jechorek, D; Reinhold, D; Wex, T; Malfertheiner, P.

in: ALIMENT PHARM THER, Jahrgang 45, Nr. 3, 02.2017, S. 417-426.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{7295942b1c004d0f8fb252c6c363040c,
title = "Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis",
abstract = "BACKGROUND: Eosinophilic oesophagitis (EoE) and gastro-oesophageal reflux disease (GERD) present with overlapping symptomatology and it is challenging to distinguish EoE from GERD clinically before endoscopy.AIM: To investigate the prognostic value of a set of clinical symptoms and laboratory values in patients with EoE and GERD.METHODS: In this prospective, single-centre, observational study, we compared clinical and laboratory data from 202 patients with EoE or GERD (10 relevant characteristics). Those characteristics showing potential significance in a univariate analysis were then included in a multivariate analysis.RESULTS: The set of 10 characteristics (10-marker set) was able to distinguish between EoE and GERD with good reliability (correct assignment, i.e. agreement with subsequent EGD, of 94.4%). Reduction of the set to the six statistically and clinically most relevant markers continued to give good reliability (88.9%), and further stepwise reduction led to four-marker sets comprising history of atopy, history of food impaction, proton pump inhibitor refractory symptoms and either immunoglobulin E or peripheral eosinophilia, with correct assignment rates of 91.3% and 85.1% respectively.CONCLUSIONS: We have developed a simple and easily applicable clinical/laboratory marker set that helps to distinguish EoE from GERD earlier in the treatment course, thus guiding the endoscopist to perform biopsies from the oesophagus to ensure the diagnosis. The application of the scoring system is expected to diagnose EoE earlier and avoiding delay of adequate treatment.",
keywords = "Adult, Aged, Aged, 80 and over, Biomarkers, Biopsy, Diagnosis, Differential, Early Diagnosis, Endoscopy, Eosinophilic Esophagitis, Female, Gastroesophageal Reflux, Health Status Indicators, Humans, Male, Middle Aged, Proton Pump Inhibitors, Reproducibility of Results, Young Adult, Journal Article, Observational Study",
author = "{von Arnim}, U and F-W R{\"o}hl and S Miehlke and D Jechorek and D Reinhold and T Wex and P Malfertheiner",
note = "{\textcopyright} 2016 John Wiley & Sons Ltd.",
year = "2017",
month = feb,
doi = "10.1111/apt.13869",
language = "English",
volume = "45",
pages = "417--426",
journal = "ALIMENT PHARM THER",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis

AU - von Arnim, U

AU - Röhl, F-W

AU - Miehlke, S

AU - Jechorek, D

AU - Reinhold, D

AU - Wex, T

AU - Malfertheiner, P

N1 - © 2016 John Wiley & Sons Ltd.

PY - 2017/2

Y1 - 2017/2

N2 - BACKGROUND: Eosinophilic oesophagitis (EoE) and gastro-oesophageal reflux disease (GERD) present with overlapping symptomatology and it is challenging to distinguish EoE from GERD clinically before endoscopy.AIM: To investigate the prognostic value of a set of clinical symptoms and laboratory values in patients with EoE and GERD.METHODS: In this prospective, single-centre, observational study, we compared clinical and laboratory data from 202 patients with EoE or GERD (10 relevant characteristics). Those characteristics showing potential significance in a univariate analysis were then included in a multivariate analysis.RESULTS: The set of 10 characteristics (10-marker set) was able to distinguish between EoE and GERD with good reliability (correct assignment, i.e. agreement with subsequent EGD, of 94.4%). Reduction of the set to the six statistically and clinically most relevant markers continued to give good reliability (88.9%), and further stepwise reduction led to four-marker sets comprising history of atopy, history of food impaction, proton pump inhibitor refractory symptoms and either immunoglobulin E or peripheral eosinophilia, with correct assignment rates of 91.3% and 85.1% respectively.CONCLUSIONS: We have developed a simple and easily applicable clinical/laboratory marker set that helps to distinguish EoE from GERD earlier in the treatment course, thus guiding the endoscopist to perform biopsies from the oesophagus to ensure the diagnosis. The application of the scoring system is expected to diagnose EoE earlier and avoiding delay of adequate treatment.

AB - BACKGROUND: Eosinophilic oesophagitis (EoE) and gastro-oesophageal reflux disease (GERD) present with overlapping symptomatology and it is challenging to distinguish EoE from GERD clinically before endoscopy.AIM: To investigate the prognostic value of a set of clinical symptoms and laboratory values in patients with EoE and GERD.METHODS: In this prospective, single-centre, observational study, we compared clinical and laboratory data from 202 patients with EoE or GERD (10 relevant characteristics). Those characteristics showing potential significance in a univariate analysis were then included in a multivariate analysis.RESULTS: The set of 10 characteristics (10-marker set) was able to distinguish between EoE and GERD with good reliability (correct assignment, i.e. agreement with subsequent EGD, of 94.4%). Reduction of the set to the six statistically and clinically most relevant markers continued to give good reliability (88.9%), and further stepwise reduction led to four-marker sets comprising history of atopy, history of food impaction, proton pump inhibitor refractory symptoms and either immunoglobulin E or peripheral eosinophilia, with correct assignment rates of 91.3% and 85.1% respectively.CONCLUSIONS: We have developed a simple and easily applicable clinical/laboratory marker set that helps to distinguish EoE from GERD earlier in the treatment course, thus guiding the endoscopist to perform biopsies from the oesophagus to ensure the diagnosis. The application of the scoring system is expected to diagnose EoE earlier and avoiding delay of adequate treatment.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Biomarkers

KW - Biopsy

KW - Diagnosis, Differential

KW - Early Diagnosis

KW - Endoscopy

KW - Eosinophilic Esophagitis

KW - Female

KW - Gastroesophageal Reflux

KW - Health Status Indicators

KW - Humans

KW - Male

KW - Middle Aged

KW - Proton Pump Inhibitors

KW - Reproducibility of Results

KW - Young Adult

KW - Journal Article

KW - Observational Study

U2 - 10.1111/apt.13869

DO - 10.1111/apt.13869

M3 - SCORING: Journal article

C2 - 27896821

VL - 45

SP - 417

EP - 426

JO - ALIMENT PHARM THER

JF - ALIMENT PHARM THER

SN - 0269-2813

IS - 3

ER -